• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Indonesia·Consumer Cyclical·DAYA.JK
Share

PT Duta Intidaya Tbk Stocks

IDR 990Last Updated 29.07.2026

Issuer Rating

3/7
Performance

Average

Risk

High

Recommendation

Sell

Market Cap

IDR 141.60M

IDR 990
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

PT Duta Intidaya Tbk operates as a prominent health and beauty retailer throughout Indonesia, offering a diverse product portfolio. Its offerings span pharmaceutical products, including medicines and various pharmacy goods, alongside medical and wellness devices. The company also supplies personal care and skincare items, fragrances, cosmetics, infant products, and a selection of general merchandise. Furthermore, it engages in the trade of food and beverage items. Beyond its retail activities, PT Duta Intidaya Tbk undertakes various roles within the supply chain, serving as an agent, sole representative, distributor, purveyor, franchisor, and supplier for a wide array of traded goods. As of December 31, 2021, the company maintained a significant physical presence with 160 Watsons-branded stores spread across 14 provinces. Its digital reach is extensive, providing products through major e-commerce platforms like Shopee.com, Tokopedia.com, Lazada.com, Blibli.com, and Bukalapak.com, as well as via applications such as Halodoc, Bima+, Good Doctor, GrabMart, and GoMart. Established in 2005 and headquartered in South Jakarta, Indonesia, the company is a subsidiary of Total Alliance Holdings Limited.

Company Valuation

Slightly overvalued
3/7

Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, of fair value on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 03:07

Apple shares fell after a weak forecast. Sales will be affected by a shortage of memory chips

31.07.2026 02:45

It's the best day for chipmakers since 2025. Burry is shorting them again.

31.07.2026 01:43

Amazon reported accelerated revenue growth in its cloud business. Its stock jumped 9%.

31.07.2026 01:27

Microsoft Beat Nvidia's Record for Market Capitalization Growth

31.07.2026 01:08

The assets of the "AI-Nostradamus" fund fell to $10 billion following the sale of part of its portfolio

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026